Möchten Sie immer auf dem neuesten Stand bleiben?

New York, USA, May 04, 2026 (GLOBE NEWSWIRE) -- Hepatic Encephalopathy Market Set for Growth at a 1.2% CAGR Through 2036, Driven by Emerging Therapies and Rising Disease Burden | DelveInsight The...

Gyre Therapeutics Completes Acquisition of Cullgen to Create U.S.- and China-based Fully Integrated Biopharmaceutical Company

EMERYVILLE, Calif., May 04, 2026 (GLOBE NEWSWIRE) -- Kyverna Therapeutics, Inc. (Nasdaq: KYTX), a late-stage clinical biopharmaceutical company focused on developing cell therapies for patients with...

Jeremy B. Fitch, MBA, appointed as Chief Business OfficerMichael A. Alrutz, J.D., Ph.D., appointed as General CounselGuy C. Ruble, PharmD, appointed as VP, Regulatory Affairs CAMBRIDGE, United...

Dublin, May 01, 2026 (GLOBE NEWSWIRE) -- The "Feline Vaccines Market Report 2026" has been added to ResearchAndMarkets.com's offering. The feline vaccines market is experiencing a robust...

Dublin, May 01, 2026 (GLOBE NEWSWIRE) -- The "Cat Vaccine Market Report 2026" has been added to ResearchAndMarkets.com's offering. The global cat vaccine market has witnessed significant...

Dublin, May 01, 2026 (GLOBE NEWSWIRE) -- The "Dog Vaccines Market Report 2026" has been added to ResearchAndMarkets.com's offering. The dog vaccines market has demonstrated significant growth,...

Dublin, May 01, 2026 (GLOBE NEWSWIRE) -- The "Pharmaceutical Manufacturing Software Market Report 2026" has been added to ResearchAndMarkets.com's offering. The pharmaceutical manufacturing...

-- First therapy to be FDA-approved and EC-authorized for acquired hypothalamic obesity -- -- European Commission grants authorization in adults and children 4 years of age and above with acquired...

Dublin, May 01, 2026 (GLOBE NEWSWIRE) -- The "Bevacizumab Biosimilars Market Report 2026" has been added to ResearchAndMarkets.com's offering. The bevacizumab biosimilars market has been...